Global Exoskeleton Market is expected to reach 8,300.00 Million by 2025 from USD 528.30 Million in 2017, at a CAGR of 41.2% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025. 1- Axis market with highest market share has the largest market segment in exoskeleton market.
Access Full Report: http://databridgemarketresearch.com/reports/global-exoskeleton-market/
The global exoskeleton market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. Raytheon Company dominates exoskeleton market, accounting for the highest market share in 2017, followed by Esco Bionics and EXHAUSS. Other players in this market include Focal Meditech BV, Cyberdyne, Inc., Bionik Laboratories corp., Lockheed Martin Corporation, GOGOA, Honda Motor Co., Ltd. and EXHAUSS among others holds 7.7% of the global exoskeleton market in 2017.
Founded in 1972 and headquartered in Walldorf Germany. Raytheon Company is the market leader in specializing in defence, security and civil markets throughout the world. The company operates in various segments namely integrated defence systems, intelligence, information and services, missile systems, space and airborne systems and Forcepoint. The company’s products and services are widely applicable in air and missile defence; land and sea-based radar solutions; command, control, communications, computers, cyber, and intelligence solutions; and naval combat and ship electronic systems.
The company has its subsidiaries namely BBN Technologies (U.S.), Raytheon Intelligence (U.S.), Forcepoint (U.S.), Raytheon systems (U.S.), Raytheon Australia (Australia), Raytheon Deutschland GmbH (Europe) and others. Raytheon Company is deeply committed to global partnerships, providing solutions and services to valued customers in 80 countries. The company has its presence worldwide some of them are Australia, Germany, United Kingdom and the United States.
Founded in 2005 and headquartered in California, U.S, Esco Bionics engages in designing, developing and selling of exoskeleton technology that currently has applications in healthcare and industrial markets. The company operates through 3 segments namely: Medical Devices, Industrial Sales, and Engineering Services. The Medical service segment designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The Industrial Sales segment designs, engineers, commercializes, and sells exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. The Engineering services segment engages in research and development service arrangements, technology license agreements, and government regulations.
The company has its global presence in North America (Canada, The U.S and Mexico).
Founded in 2003 and situated in Aulnay sous bois, France. EXHAUSS is focused in providing and developing functional exoskeletons to assist the worker's efforts to lift his tools or loads. EXHAUSS received won 4 innovation awards in spring 2014. Its patents mainly focus over the mechatronization of passive mechanical structures of effort assistance. The company has its products offerings through different models of exoskeleton namely model P, model W, model H and among others. The company’s products and services are widely applicable in logistics, industries and others.
The company has its presence in the regions of France and provides its products and services to other areas through local sales partners.
Global Medical Exoskeleton Market – Industry Trends and Forecast to 2027
Global Soft Exoskeleton Market – Industry Trends and Forecast to 2026
Global Exoskeleton Market- Industry Trends and Forecast to 2025
North America Exoskeleton Market– Industry Trends and Forecast to 2025
Europe Exoskeleton Market - Industry Trends and Forecast to 2025
Asia Pacific Exoskeleton Market- Industry Trends and Forecast to 2025